Detalhe da pesquisa
1.
Combining tumor deposits with the number of lymph node metastases to improve the prognostic accuracy in stage III colon cancer: a post hoc analysis of the CALGB/SWOG 80702 phase III study (Alliance)â.
Ann Oncol
; 32(10): 1267-1275, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34293461
2.
Antitumor activity of ipatasertib combined with chemotherapy: results from a phase Ib study in solid tumors.
Ann Oncol
; 31(5): 626-633, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32205017
3.
Randomized, double-blind, placebo-controlled phase II study of istiratumab (MM-141) plus nab-paclitaxel and gemcitabine versus nab-paclitaxel and gemcitabine in front-line metastatic pancreatic cancer (CARRIE).
Ann Oncol
; 31(1): 79-87, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31912800
4.
Phase Ib study of atezolizumab combined with cobimetinib in patients with solid tumors.
Ann Oncol
; 30(7): 1134-1142, 2019 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30918950
5.
Phase 1b investigation of the MEK inhibitor binimetinib in patients with advanced or metastatic biliary tract cancer.
Invest New Drugs
; 36(6): 1037-1043, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29785570
6.
A multicenter, open-label, expanded phase 2 study to evaluate the safety and efficacy of etirinotecan pegol, a polymer conjugate of irinotecan, in women with recurrent platinum-resistant or refractory ovarian cancer.
Gynecol Oncol
; 147(2): 276-282, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28935273
7.
Ramucirumab combined with FOLFOX as front-line therapy for advanced esophageal, gastroesophageal junction, or gastric adenocarcinoma: a randomized, double-blind, multicenter Phase II trial.
Ann Oncol
; 27(12): 2196-2203, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27765757
8.
Randomized phase II study of modified FOLFOX-6 in combination with ramucirumab or icrucumab as second-line therapy in patients with metastatic colorectal cancer after disease progression on first-line irinotecan-based therapy.
Ann Oncol
; 27(12): 2216-2224, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27733377
9.
A phase Ib dose-escalation study of the MEK inhibitor trametinib in combination with the PI3K/mTOR inhibitor GSK2126458 in patients with advanced solid tumors.
Invest New Drugs
; 34(6): 740-749, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27450049
10.
Phase I study of olaparib plus gemcitabine in patients with advanced solid tumours and comparison with gemcitabine alone in patients with locally advanced/metastatic pancreatic cancer.
Ann Oncol
; 26(4): 804-811, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25573533
11.
Corrigendum to 'Randomized, double-blind, placebo-controlled phase II study of istiratumab (MM-141) plus nab-paclitaxel and gemcitabine versus nab-paclitaxel and gemcitabine in front-line metastatic pancreatic cancer (CARRIE)': Annals of Oncology, Volume 31, Issue 1, 2020, Pages 79-87.
Ann Oncol
; 31(8): 1094, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32507672
12.
A phase IB trial of the oral MEK inhibitor trametinib (GSK1120212) in combination with everolimus in patients with advanced solid tumors.
Ann Oncol
; 26(1): 58-64, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25344362
13.
Intermittent dosing of axitinib combined with chemotherapy is supported by (18)FLT-PET in gastrointestinal tumours.
Br J Cancer
; 110(4): 875-81, 2014 Feb 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-24423921
14.
Phase I study of weekly paclitaxel in combination with pazopanib and lapatinib in advanced solid malignancies.
Br J Cancer
; 110(11): 2647-54, 2014 May 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-24800949
15.
A phase I dose escalation study of oral c-MET inhibitor tivantinib (ARQ 197) in combination with gemcitabine in patients with solid tumors.
Ann Oncol
; 25(7): 1416-1421, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24737778
16.
Ramucirumab combined with FOLFOX as front-line therapy for advanced esophageal, gastroesophageal junction, or gastric adenocarcinoma: a randomized, double-blind, multicenter Phase II trial.
Ann Oncol
; 30(12): 2016, 2019 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31893488
17.
Consideration of an association between performance status and ramucirumab efficacy.
Ann Oncol
; 28(4): 902-903, 2017 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28203696
18.
Estradiol-17 beta stimulates DNA synthesis in rat granulosa cells: action mediated by transforming growth factor-beta.
Endocrinology
; 128(5): 2663-5, 1991 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-2019275
19.
Rat thecal/interstitial cells secrete a transforming growth factor-beta-like factor that promotes growth and differentiation in rat granulosa cells.
Endocrinology
; 123(2): 941-8, 1988 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-3135176
20.
Epidermal growth factor influences growth and differentiation of rat granulosa cells.
Endocrinology
; 127(2): 533-40, 1990 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-2115428